Over the past 19 years of practice, Tom Selby has concentrated his practice in two (usually) distinct areas: patent litigation and professional liability defense. He serves as Co-Head of the firm’s Patent Litigation practice group working on patent and licensing litigation, and at the same time represents accounting firms in major regulatory and trial matters.
Tom has represented clients in intellectual property disputes over software, biotech, pharmaceutical, medical device, and communications technologies. He served as lead counsel to Pfizer at a bench trial over the major cancer treatment Sutent®, in which Pfizer prevailed on all issues. In 2014, in addition to ongoing matters for Pfizer, he represented Intel in trade secrets litigation, and Novartis subsidiary Alcon in Hatch-Waxman litigation. Tom was lead counsel for ACell, Inc. in successful inter partes interference proceedings, that followed successful federal court litigation. Tom has been recognized as a “Life Science Star” in the 2015-2018 editions of LMG Life Sciences and as a “Leading Patent Litigation Attorney” by IAM Patent 1000 from 2016-2019. In 2019, Tom was recognized as an “IP Star” by Managing IP, which noted Tom “is an even-keeled, cerebral lawyer who doesn’t get flustered in complex life sciences and high-technology cases.” Benchmark Litigation also recognized Tom as a “Future Star” in 2019.
The other major focus of his practice is accountants’ liability: for more than a decade, Tom has represented a national audit and accounting firm in over 35 litigation and regulatory matters. Tom served as co-lead defending accountants in litigation over the Madoff fraud, and in the collapse of the Sentinel investment firm, in which the principal was convicted in what prosecutors called one of the largest criminal fraud cases ever to come out of Chicago. Although the vast bulk of these accounting matters involved GAAP and GAAS disputes, Tom has also handled litigation involving tax services, securities, non-competition, and employment/whistleblower issues. Tom has represented accountants and auditors in investigations by the Securities and Exchange Commission, Department of Justice, the federal Office of Inspector General, the Commodity Futures Trading Commission, and the United States Congress.
Updated Oct 2021